2019
DOI: 10.1016/j.trac.2019.05.027
|View full text |Cite
|
Sign up to set email alerts
|

Functional nucleic acids tailoring and its application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 53 publications
(19 citation statements)
references
References 131 publications
0
16
0
1
Order By: Relevance
“…[57] Aptamers boast advantages that distinguish them from antibodies. For example, aptamers: i) can be easily and economically obtained; ii) can be subjected to a selection process noted for the low toxicity and low immunogenicity of the targets; iii) can have better specificity and affinity than antibodies; iv) are easy to be modified chemically; v) have better thermal stability; vi) can be linked with other drugs for combination therapy; vii) possess features which can be easily tailored, for example by splitting, deleting, substitution, fusion, and elongation, [58] to improve performance, particularly regarding realizing replacements for protein-based antibodies and the direct detection of small molecules as a result of the development of split aptamer technology; and viii) include varieties such as Mango and Spinach, which can be used to readily couple the binding of small molecules to enhance fluorescent signals. Therefore, they can be used as specific nucleic acid probes in vivo or as fluorescence switch elements in biosensors.…”
Section: Aptamersmentioning
confidence: 99%
“…[57] Aptamers boast advantages that distinguish them from antibodies. For example, aptamers: i) can be easily and economically obtained; ii) can be subjected to a selection process noted for the low toxicity and low immunogenicity of the targets; iii) can have better specificity and affinity than antibodies; iv) are easy to be modified chemically; v) have better thermal stability; vi) can be linked with other drugs for combination therapy; vii) possess features which can be easily tailored, for example by splitting, deleting, substitution, fusion, and elongation, [58] to improve performance, particularly regarding realizing replacements for protein-based antibodies and the direct detection of small molecules as a result of the development of split aptamer technology; and viii) include varieties such as Mango and Spinach, which can be used to readily couple the binding of small molecules to enhance fluorescent signals. Therefore, they can be used as specific nucleic acid probes in vivo or as fluorescence switch elements in biosensors.…”
Section: Aptamersmentioning
confidence: 99%
“…[61] Aptamere haben spezifische Vorteile, die sie von Antikçrpern unterscheiden. FĂźr Aptamere gilt beispielsweise, dass sie (i) einfach und çkonomisch zugänglich sich, (ii) sich durch einen Selektionsprozess auszeichnen, der durch eine geringe Toxizität und eine niedrige Immunogenität der ZielmolekĂźle nicht beeinflusst wird, (iii) eine hçhere Spezifität und Affinität als Antikçrper haben kçnnen, (iv) leicht chemisch modifizierbar sind, (v) thermisch stabiler sind, (vi) fĂźr Kombinationstherapien mit anderen Wirkstoffen verknĂźpft werden kçnnen, (vii) Merkmale aufweisen, die leicht maßgeschneidert werden kçnnen -einschließlich ihrer Spaltung, Entfernung, Substitution, Fusion und Verlängerung -, [62] um die Leistung zu verbessern, insbesondere im Hinblick auf den mçglichen Ersatz von Antikçrpern und den direkten Nachweis kleiner MolekĂźle, und (viii) Varianten einschließen, die eine einfache Kopplung der Bindung kleiner MolekĂźle mit der Verstärkung der Fluoreszenzsignale erlauben. Aus letzterem Grund kçnnen sie als spezifische In-vivo-Nukleinsäuresonden oder als Fluoreszenzschalter in Biosensoren eingesetzt werden.…”
Section: Aptamereunclassified
“…A nucleic acid aptamer is a short, single-stranded sequence composed of dozens of deoxyribonucleotides or ribonucleotides (Xiao et al, 2019). These aptamers can be folded to form the specific structures that bind with target molecules, such as small molecules, ions, and protein molecules (Xu et al, 2017).…”
Section: The Nucleic Acid Amplification Technology and Functional Nucleic Acid Aptamersmentioning
confidence: 99%